Human amniotic epithelial cells can differentiate into granulosa cells and restore folliculogenesis in a mouse model of chemotherapy-induced premature ovarian failure

Stem Cell Research and Therapy

Volumn 4, Issue 5, 2013, Pages

  Wang, Fangyuan ^a   Wang, Li ^a   Yao, Xiaofen ^a   Lai, Dongmei ^a   Guo, Lihe ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; BUSULFAN; CYCLOPHOSPHAMIDE; CYTOGLOBIN; EOSIN; GREEN FLUORESCENT PROTEIN; HEMATOXYLIN; HLA DR ANTIGEN; LENTIVIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; MUELLERIAN INHIBITING FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; ONCOPROTEIN; RNA HELICASE; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR NANOG;

AMNION CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GRANULOSA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; OVARY CELL; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

MUS;

AMNION; ANIMALS; ANTI-MULLERIAN HORMONE; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GRANULOSA CELLS; HELA CELLS; HUMANS; MICE; MICE, INBRED C57BL; OVARIAN FOLLICLE; PRIMARY OVARIAN INSUFFICIENCY; TIME FACTORS;

EID: 84885355102     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt335     Document Type: Article

References (39)

1. The effects of radiotherapy and chemotherapy on female reproduction. Meirow D, Nugent D, Hum Reprod Update 2001 7 535 543 10.1093/humupd/7.6.535 11727861 (Pubitemid 33069611)
2. Transmission of malignant cells in ovarian grafts. Gosden RG, Rutherford AJ, Norfolk DR, Hum Reprod 1997 12 403 (Pubitemid 27156421)
3. Oncological implications in the replacement of ovarian tissue. Shaw J, Trounson A, Hum Reprod 1997 12 403 405 (Pubitemid 27156422)
4. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. Blumenfeld Z, Avivi I, Ritter M, Rowe JM, J Soc Gynecol Investig 1999 6 229 239 10.1016/S1071-5576(99) 00028-3 10554760 (Pubitemid 29494928)
5. Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a. Blumenfeld Z, Eckman A, J Natl Cancer Inst Monogr 2005 34 40 43 15784821
6. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, Giordano M, Garrone O, Pronzato P, Bighin C, Levaggi A, Giraudi S, Cresti N, Magnolfi E, Scotto T, Vecchio C, Venturini M, JAMA 2011 306 269 276 10.1001/jama.2011.991 21771987
7. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Johnson J, Bagley J, Skaznik-Wikiel M, Lee HJ, Adams GB, Niikura Y, Tschudy KS, Tilly JC, Cortes ML, Forkert R, Spitzer T, Iacomini J, Scadden DT, Tilly JL, Cell 2005 122 303 315 10.1016/j.cell.2005.06. 031 16051153 (Pubitemid 41032992)
8. Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. Lee HJ, Selesniemi K, Niikura Y, Niikura T, Klein R, Dombkowski DM, Tilly JL, J Clin Oncol 2007 25 3198 3204 10.1200/JCO.2006.10.3028 17664466 (Pubitemid 47325602)
9. Ovulated oocytes in adult mice derive from non-circulating germ cells. Eggan K, Jurga S, Gosden R, Min IM, Wagers AJ, Nature 2006 441 1109 1114 10.1038/nature04929 16799565 (Pubitemid 43990726)
10. Transplanted bone marrow cells do not provide new oocytes but rescue fertility in female mice following treatment with chemotherapeutic agents. Santiquet N, Vallières L, Pothier F, Sirard MA, Robert C, Richard F, Cell Reprogram 2012 14 123 129 22471934
11. Stem cell characteristics of amniotic epithelial cells. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC, Stem Cells 2005 23 1549 1555 10.1634/stemcells. 2004-0357 16081662 (Pubitemid 41741004)
12. Stem cells derived from human fetal membranes display multilineage differentiation potential. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U, Biol Reprod 2007 77 577 588 10.1095/biolreprod.106.055244 17494917 (Pubitemid 47328622)
13. Human amnion epithelial cells can be induced to differentiate into functional insulin-producing cells. Hou Y, Huang Q, Liu T, Guo L, Acta Biochim Biophys 2008 40 830 839
14. Human amniotic membrane as an alternative source of stem cells for regenerative medicine. Díaz-Prado S, Muiños-López E, Hermida-Gómez T, Cicione C, Rendal-Vázquez ME, Fuentes-Boquete I, de Toro FJ, Blanco FJ, Differentiation 2011 81 162 171 10.1016/j.diff.2011.01. 005 21339039
15. Amnion-derived stem cells: in quest of clinical applications. Miki T, Stem Cell Res Ther 2011 2 25 10.1186/scrt66 21596003
16. Human amniotic epithelial cells differentiate into cells expressing germ cell specific markers when cultured in medium containing serum substitute supplement. Evron A, Goldman S, Shalev E, Reprod Biol Endocrinol 2012 10 108 10.1186/1477-7827-10-108 23241213
17. Production of offspring from a germline stem cell line derived from neonatal ovaries. Zou K, Yuan Z, Yang Z, Luo H, Sun K, Zhou L, Xiang J, Shi L, Yu Q, Zhang Y, Hou R, Wu J, Nat Cell Biol 2009 11 631 636 10.1038/ncb1869 19363485
18. Human amniotic epithelial cells ameliorate behavioral dysfunction and reduce infarct size in the rat middle cerebral artery occlusion model. Liu T, Wu J, Huang Q, Hou Y, Jiang Z, Zang S, Guo L, Shock 2008 29 603 611 18414234 (Pubitemid 351544081)
19. Effect of cyclophosphamide on oocyte and follicle number in Sprague-Dawley rats, C57BL/6N and DBA/2N mice. Shiromizu K, Thorgeirsson SS, Mattison DR, Pediatr Pharmacol 1984 4 213 221 (Pubitemid 15181777)
20. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL, Nature 2004 428 145 150 10.1038/nature02316 15014492 (Pubitemid 38374304)
21. Gonadotropin receptors and the control of gonadal steroidogenesis: physiology and pathology. Misrahi M, Beau I, Meduri G, Bouvattier C, Atger M, Ghinea N, Hai MV, Bougnères PF, Milgrom E, Baillieres Clin Endocrinol Metab 1998 12 35 66 10.1016/S0950-351X(98)80444-8 9890061 (Pubitemid 28495389)
22. Anti-Müllerian hormone: a new marker for ovarian function. Visser JA, de Jong FH, Laven JS, Themmen AP, Reproduction 2006 131 1 9 10.1530/rep.1.00529 16388003 (Pubitemid 43230697)
23. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K, American Society of Clinical Oncology, J Clin Oncol 2006 24 2917 29131 10.1200/JCO.2006.06.5888 16651642 (Pubitemid 46655598)
24. Bone marrow transplantation restores follicular maturation and steroid hormones production in a mouse model for primary ovarian failure. Ghadami M, El-Demerdash E, Zhang D, Salama SA, Binhazim AA, Archibong AE, Chen X, Ballard BR, Sairam MR, Al-Hendy A, PLoS One 2012 7 32462 10.1371/journal.pone.0032462 22412875
25. Placental mesenchymal stem cells as potential autologous graft for pre and perinatal neuroregeneration. Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, Surbek DV, Am J Obstet Gynecol 2006 194 664e73
26. Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl(4)-treated mice. Manuelpillai U, Tchongue J, Lourensz D, Vaghjiani V, Samuel CS, Liu A, Williams ED, Sievert W, Cell Transplant 2010 19 1157e68
27. In vivo differentiation of human amniotic epithelial cells into cardiomyocyte-like cells and cell transplantation effect on myocardial infarction in rats: comparison with cord blood and adipose tissue-derived mesenchymal stem cells. Fang CH, Jin J, Joe JH, Song YS, So BI, Lim SM, Cheon GJ, Woo SK, Ra JC, Lee YY, Kim KS, Cell Transplant 2012 21 1687 1696 10.3727/096368912X653039 22776022
28. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Visser JA, Schipper I, Laven JS, Themmen AP, Nat Rev Endocrinol 2012 8 331 341 10.1038/nchembio.912 22231848
29. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. Hagen CP, Aksglaede L, Sørensen K, Main KM, Boas M, Cleemann L, Holm K, Gravholt CH, Andersson AM, Pedersen AT, Petersen JH, Linneberg A, Kjaergaard S, Juul A, J Clin Endocrinol Metab 2010 95 5003 5010 10.1210/jc.2010-0930 20719830
30. Pretreatment serum anti-Müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. Anderson RA, Cameron DA, J Clin Endocrinol Metab 2011 96 1336 1343 10.1210/jc.2010-2582 21325458
31. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Kohno T, Anzai T, Naito K, Miyasho T, Okamoto M, Yokota H, Yamada S, Maekawa Y, Takahashi T, Yoshikawa T, Ishizaka A, Ogawa S, Cardiovasc Res 2009 81 565 573 18984601
32. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS, Lancet 2003 362 697 703 10.1016/S0140-6736(03)14232-8 12957092 (Pubitemid 37101067)
33. Multipotent adult progenitor cells sustain function of ischemic limbs in mice. Aranguren XL, McCue JD, Hendrickx B, Zhu XH, Du F, Chen E, Pelacho B, Peñuelas I, Abizanda G, Uriz M, Frommer SA, Ross JJ, Schroeder BA, Seaborn MS, Adney JR, Hagenbrock J, Harris NH, Zhang Y, Zhang X, Nelson-Holte MH, Jiang Y, Billiau AD, Chen W, Prósper F, Verfaillie CM, Luttun A, J Clin Invest 2008 118 505 514 18172550 (Pubitemid 351206541)
34. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nygren JM, Jovinge S, Breitbach M, Säwén P, Röll W, Röll W, Hescheler J, Taneera J, Fleischmann BK, Jacobsen SE, Nat Med 2004 10 494 501 10.1038/nm1040 15107841 (Pubitemid 38667908)
35. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. Chavakis E, Urbich C, Dimmeler S, J Mol Cell Cardiol 2008 45 514 522 10.1016/j.yjmcc.2008.01.004 18304573
36. Immunogenicity of human amniotic membrane in experimental xenotransplantation. Kubo M, Sonoda Y, Muramatsu R, Usui M, Invest Ophthalmol Vis Sci 2001 42 1539 1546 11381058 (Pubitemid 32520745)
37. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL, Nat Med 2012 18 413 421 10.1038/nm.2669 22366948
38. The effect of "activated" cyclophosphamide on human and rat ovarian granulosa cells in vitro. Ataya KM, Pydyn EF, Ramahi-Ataya AJ, Reprod Toxicol 1990 4 121 125 10.1016/0890-6238(90)90006-H 2136026
39. Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Banas RA, Trumpower C, Bentlejewski C, Marshall V, Sing G, Zeevi A, Hum Immunol 2008 69 321 328 10.1016/j.humimm.2008.04.007 18571002